Eckert & Ziegler with Record Results in FY 2021 and Positive Outlook

 

Berlin, 30 March 2022. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) achieved sales of EUR 180.4 million in fiscal year 2021 (previous year: EUR 176.1 million). The consolidated net income for the year reached a new…

2 Min
More

Bayer to strengthen global Pharmaceuticals production network

Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical…

4 Min
More

BIOTRONIK Patient App Facilitates Digital Patient Engagement

BIOTRONIK Patient App is available for patients with a compatible BIOTRONIK cardiac device

 

2 Min
More

Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials

Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Theranostics Inc. (Alpha-9) a clinical supply agreement for Eckert & Ziegler's medical radioisotope Lutetium-177…

2 Min
More

Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market

Berlin, 22 March 2022. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) and Sirtex Medical (Sirtex) have extended their long-term supply agreement for the use of yttrium-90 in Sirtex microspheres for the treatment of liver cancer to the Chinese…

3 Min
More

Supply Chain Resilience Platform: Matchmaking to set up new supply chains

 

Europe is facing a number of economic, environmental and social challenges, most notably the crisis in Ukraine, with businesses severely affected by supply chain disruptions. To address these challenges, the European Union (EU) has launched new mea…

2 Min
More

Interview with: Prof. Georg N. Duda and Bianca Lemke, Charité and cooperation partner Dr. Lutz Kloke, Cellbricks

Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…

4 Min
More

Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO

 

Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of Adrenomed, effective today. Dr. Jones brings over 25 years of experience…

3 Min
More

Planck Institute of Molecular Plant Physiology developed a novel strategy to identify protein-molecules that have regulatory functions in stress reduction

Cinderella of chemical biology

 

3 Min
More
Show more items